← Evidence map

ArticleLeukemia2016

FOXM1 is a therapeutic target for high-risk multiple myeloma.

C Gu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

37 papers cite it

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 26648534